SecBot

SecBot
NYSE· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0000885725

BSX

BOSTON SCIENTIFIC CORP
$42.71 ▼ -1.20%
Prev close $43.23
Market cap$63.3B
ConsensusBuy
12-mo target$60.79 (+42.3%)
▲ Bullish
Analyst conviction 8/10
Insider Buying Cluster (3 insiders)High Impact Filing (7/10)30 New Institutional Positions20 Institutional ExitsCongressional Activity (3) Healthcare & Medical Devices
Snapshot
The big-picture read on BSX right now — valuation, ownership and activity at a glance.
Market Cap
$63.3B
Cap Size
Large Cap
Analyst Consensus
Strong Buy (79%)
Inst. Holders
50 funds
Inst. Value
$42.7B
Inst. Activity
30 buys / 20 sells
Insider Activity
$10.0M buy / $0.00 sell
Insider Net $
$10.0M
Social Sentiment
78° Bullish
SEC Reports
17
Congressional
13 trades
Price chart 30d -11.7%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 8, 2026 ftd
FTD: BSX — 24,075 shares ($1.2M) failed to deliver
Settlement: 20260908, Price: $47.80, FTD Value: $1,150,785, BOSTON SCIENTIFIC CORP
Sep 2, 2026 Insider
O'Connor Padraig Andrew acquired via exercise 1,171 shares
EVP, Global Operations
Sep 2, 2026 Insider
O'Connor Padraig Andrew surrendered for taxes 567 shares
EVP, Global Operations @ $48.37 ($27.4K)
Sep 1, 2026 SEC
A federal magistrate judge barred the plaintiffs' economic expert in a single product-liability case against Boston Scie
COURT-RULING — Impact 2/10
Aug 31, 2026 Event
SANTIAGO et al v. BOSTON SCIENTIFIC CORPORATION
Court ruling (njd) — Docket: 2:21-cv-11696
Aug 26, 2026 SEC
Boston Scientific disclosed a cybersecurity incident on August 25, 2026, that has caused a global disruption to its oper
8-K — Impact 6/10
Aug 25, 2026 Insider
Morano Susan E bought 2,040 shares
Director @ $49.22 ($100.4K)
Aug 22, 2026 SEC
Boston Scientific's Q2 2026 earnings beat was overshadowed by a significant guidance cut and a $700M-$800M restructuring
INST-CLUSTER — Impact 6/10
Analyst ratings buy % -12.2%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Buy 79% rate it Buy or better · 38 analysts
Strong Buy 11 29% Buy 19 50% Hold 8 21% Sell 0 0% Strong Sell 0 0%
Recent analyst actions
DateFirmActionRatingFirm rating
Sep 24, 2026Wells FargoMAINTAINEqual-Weight 54%
Sep 21, 2026OppenheimerMAINTAINOutperform 52%
Sep 17, 2026CitigroupDOWNGRADENeutral 55%
Sep 9, 2026BTIGMAINTAINBuy 53%
Aug 25, 2026TD CowenREITERATEBuy 56%
Jul 31, 2026Argus ResearchDOWNGRADEHold 54%
Jul 30, 2026UBSMAINTAINBuy 55%
Jul 30, 2026CitigroupMAINTAINBuy 55%
Jul 30, 2026RBC CapitalMAINTAINOutperform 55%
Jul 30, 2026TD CowenMAINTAINBuy 56%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 2026111980079%
Aug 1, 2026111980079%
Jul 1, 2026121980079%
Jun 1, 2026122080080%
May 1, 2026132350088%
Apr 1, 2026132530093%
Mar 1, 2026142330093%
Feb 1, 2026152230093%
Price targets
Where 29 covering analysts think BSX trades over the next 12 months.
$60.79 +42.3% upside Strong Buy
Current$42.71 Low$44.00 Median$60.00 High$94.00 29 analysts
$44.00$94.00
Analyst rating Buy· 1.6/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
78°
Bullish
BearishNeutralBullish
12 mentions 10 bullish 1 bearish 1 neutral
Recent posts
stocks Bullish 7d 23h ago
Boston Scientific $BSX - A Life-Saving Medical Devices Champion
▲ 1 · 💬 1· ⚡ 0.5
wallstreetbets Neutral 10d 22h ago
BSX looking good n cheap at these levels. Ready for a run up
▲ 2 · 💬 2· ⚡ 0.5
stocks Bullish 14d 4h ago
Boston Scientific peaked at $105 last November. It closed yesterday at $43.55
▲ 267 · 💬 42· ⚡ 56.1
stocks Bullish 1mo ago
$TTD will be $20+ within a year
▲ 1 · 💬 5· ⚡ 0.5
stocks Bullish 2mo ago
BSX Earnings. Another undervalued MedTech name.
▲ 1 · 💬 3· ⚡ 0.5
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
17 SEC filing reports analyzed · 3 bullish, 3 bearish, 3 mixed, 8 neutral · avg impact 4.6/10.
NEUTRALCOURT-RULING2/10
A federal magistrate judge barred the plaintiffs' economic expert in a single product-liability case
Sep 1, 2026
BEARISH8-K6/10
Boston Scientific disclosed a cybersecurity incident on August 25, 2026, that has caused a global di
Aug 26, 2026
MIXEDINST-CLUSTER6/10
Boston Scientific's Q2 2026 earnings beat was overshadowed by a significant guidance cut and a $700M
Aug 22, 2026
MIXEDCLUSTER6/10
Boston Scientific CEO Michael Mahoney and Director David Habiger made open-market purchases totaling
Aug 12, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 8, 2026
ftd
FTD: BSX — 24,075 shares ($1.2M) failed to deliver
Settlement: 20260908, Price: $47.80, FTD Value: $1,150,785, BOSTON SCIENTIFIC CORP
Sep 7, 2026
dark_pool
Dark Pool: BSX — 25.4M shares, 213,751 trades
Week starting 2026-09-07. Total ATS volume: 25,449,353 shares across 213,751 trades.
Aug 31, 2026
short_interest_report
Short Interest: BSX up 74% to 48.2M shares
Settlement 2026-08-31 | Days to cover: 2.29 | ≈3.32% of shares outstanding (est.)
Aug 31, 2026
dark_pool
Dark Pool: BSX — 18.6M shares, 198,514 trades
Week starting 2026-08-31. Total ATS volume: 18,613,325 shares across 198,514 trades.
Aug 31, 2026
Enforcement
SANTIAGO et al v. BOSTON SCIENTIFIC CORPORATION
Court ruling (njd) — Docket: 2:21-cv-11696
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$0.76$0.58–$0.841.5%-5.5%0↑ 21↓$5.1B22
Next Q$0.84$0.82–$0.914.6%+0.0%0↑ 21↓$5.4B21
Current FY$3.26$3.16–$3.376.7%-1.2%0↑ 25↓$21.2B25
Next FY$3.41$3.19–$3.904.5%-0.7%0↑ 3↓$22.2B26
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$0.761—
7d ago$0.767-0.006
30d ago$0.805-0.044
60d ago$0.805-0.044
90d ago$0.839-0.078
Institutional ownership
Which big funds own BSX (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $42.7B total value (991,077,941 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 30 institutions added/increased vs 20 reduced.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
BlackRock, Inc.129,680,916$5.5B12.9%—
VANGUARD CAPITAL MANAGEMENT LLC97,087,553$4.1B9.7%—
STATE STREET CORP70,111,196$3.0B7.0%—
PRIMECAP MANAGEMENT CO/CA/50,520,914$2.2B5.0%ADD +55.3%
FMR LLC45,702,845$2.0B4.6%TRIM -38.4%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/24,859,191$1.5B3.5%DOUBLED +126.1%
GEODE CAPITAL MANAGEMENT, LLC33,440,102$1.4B3.3%—
VANGUARD PORTFOLIO MANAGEMENT LLC29,792,794$1.3B3.0%—
D. E. Shaw & Co., Inc.25,457,409$1.1B2.5%—
JPMORGAN CHASE & CO23,907,838$1.0B2.4%TRIM -28.3%
Recent position changes
FundActionPrevCurrentChangeValue
PRIMECAP MANAGEMENT CO/CA/ADD32,529,77450,520,914+55.3%$2.2B
FMR LLCTRIM74,226,39545,702,845-38.4%$2.0B
MASSACHUSETTS FINANCIAL SERVICES CO /MA/DOUBLED10,996,57224,859,191+126.1%$1.5B
JPMORGAN CHASE & COTRIM33,350,15723,907,838-28.3%$1.0B
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD13,891,66823,293,913+67.7%$994.2M
NORGES BANKNEW—21,170,029—$903.5M
Capital Research Global InvestorsDOUBLED7,080,88714,180,571+100.3%$605.3M
BANK OF AMERICA CORP /DE/TRIM22,756,64613,027,783-42.8%$556.0M
FIL LtdDOUBLED3,214,11612,332,054+283.7%$526.3M
JANE STREET GROUP, LLCDOUBLED4,032,11712,087,991+199.8%$515.9M
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
15 insiders, 50 transactions. Net $10.0M — $10.0M bought, $0.00 sold.
DateInsiderTitleTypeSharesPriceValue
Sep 2, 2026O'Connor Padraig AndrewEVP, Global OperationsEXERCISE1,171——
Sep 2, 2026O'Connor Padraig AndrewEVP, Global OperationsTAX W/H567$48.37$27.4K
Aug 25, 2026Morano Susan EDirectorBUY2,040$49.22$100.4K
Aug 11, 2026Woodworth EmilySVP, Global Controller and CAOI2,930$51.19$150.0K
Aug 10, 2026Monson JonathanEVP and CFOI9,908$50.46$500.0K
Aug 5, 2026Habiger David CDirectorBUY2,100$47.59$99.9K
Aug 4, 2026Habiger David CDirectorBUY140$48.59$6.8K
Aug 3, 2026Mahoney Michael FChairman, President & CEOI22,119$48.43$1.1M
Aug 3, 2026Habiger David CDirectorBUY1,042$48.07$50.1K
Aug 3, 2026Mahoney Michael FChairman, President & CEOBUY186,240$48.33$9.0M
Congressional trades
BSX trades disclosed by members of Congress, with disclosure delay.
5 members · 9 buys / 4 sells
DateMemberPartyChamberTypeAmountAssetDisclosed
Aug 18, 2026Gilbert CisnerosDHOUSEBUY$1,001 - $15,000Boston Scientific CorpSep 11, 2026(25d)
Aug 10, 2026Ro KhannaDHOUSEBUY$1,001 - $15,000Boston Scientific CorpSep 7, 2026(29d)
Jul 7, 2026Ro KhannaDHOUSESELL$1,001 - $15,000Boston Scientific CorpAug 12, 2026(37d)
Jun 5, 2026Gilbert CisnerosDHOUSEBUY$1,001 - $15,000Boston Scientific CorpJul 3, 2026(29d)
Jun 5, 2026Gilbert CisnerosDHOUSESELL$1,001 - $15,000Boston Scientific CorpJul 3, 2026(29d)
Jun 4, 2026John BoozmanRSENATESELL$1,001 - $15,000Boston Scientific CorpJul 13, 2026(40d)
Jun 2, 2026Ro KhannaDHOUSEBUY$1,001 - $15,000Boston Scientific CorpJul 8, 2026(37d)
Mar 30, 2026Ro KhannaDHOUSEBUY$15,001 - $50,000Boston Scientific CorpApr 9, 2026(11d)
Mar 27, 2026Michael McCaulRHOUSEBUY$1,001 - $15,000Boston Scientific CorpApr 10, 2026(15d)
Feb 10, 2026Gilbert CisnerosDHOUSEBUY$1,001 - $15,000Boston Scientific CorpMar 10, 2026(29d)
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for BSX.
Shares short
46,504,769
Settlement Sep 15, 2026
Change vs prior
-3.5%
Semi-monthly cycle
Days to cover
2.4
At avg daily volume
Of shares outstanding
≈3.2%
Estimate — not % of float
All BSX filing & press-release reports (17)